Findings could identify aggressive breast cancers that will respond to immunotherapy

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger researchers discovered a biological signature that could help identify which triple negative breast cancers might respond to immunotherapy and other treatments.